But have pharma and payers learned enough from earlier pilots to make modern risk-sharing deals work?
The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.
MM&M last year named its inaugural class of 16 Femmes and 20 Women to Watch. Who should be considered for this year's list of breakthough women?
He is replacing Martin Golden, who was appointed head of global marketing strategy.